Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Iacopo Pietrini"'
Autor:
Iacopo Pietrini, Gabriella Fontanini, Agnese Proietti, Rossella Bruno, Giulia Pasquini, Sabrina Cappelli, Antonio Chella, Greta Alì, Enrico Vasile, Anello Marcello Poma
Publikováno v:
Cancers, Vol 13, Iss 3828, p 3828 (2021)
Cancers
Volume 13
Issue 15
Cancers
Volume 13
Issue 15
Pembrolizumab has been approved as first-line treatment for advanced Non-small cell lung cancer (NSCLC) patients with tumors expressing PD-L1 and in the absence of other targetable alterations. However, not all patients that meet these criteria have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5969f2631f020f3423cf51acd98cbbcc
https://www.mdpi.com/2072-6694/13/15/3828
https://www.mdpi.com/2072-6694/13/15/3828
Autor:
Poma, Anello Marcello1 (AUTHOR) marcello.poma@med.unipi.it, Bruno, Rossella2 (AUTHOR) rossella.bruno@for.unipi.it, Pietrini, Iacopo3 (AUTHOR) iacopo.petrini@unipi.it, Alì, Greta2 (AUTHOR) greta.ali@gmail.com, Pasquini, Giulia4 (AUTHOR) g.pasquini988@gmail.com, Proietti, Agnese2 (AUTHOR) agneseproietti@gmail.com, Vasile, Enrico5 (AUTHOR) envasile@gmail.com, Cappelli, Sabrina5 (AUTHOR) sabrina.cap@tiscali.it, Chella, Antonio5 (AUTHOR) anto.kell@tiscali.it, Fontanini, Gabriella1 (AUTHOR) gabriella.fontanini@med.unipi.it
Publikováno v:
Cancers. Aug2021, Vol. 13 Issue 15, p3828-3828. 1p.